Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Retroviral Agent”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002415
What this trial is testing

Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients

Who this might be right for
HIV Infections
Gilead Sciences 175
Early research (Phase 1)Study completedNCT00000893
What this trial is testing

Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 103
Early research (Phase 1)Study completedNCT00000952
What this trial is testing

Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT00001091
What this trial is testing

Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Post-approval studies (Phase 4)Study completedNCT00617643
What this trial is testing

Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
Makerere University 18
Not applicableStudy completedNCT00004735
What this trial is testing

The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 81
Testing effectiveness (Phase 2)Study completedNCT00004852
What this trial is testing

Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00006211
What this trial is testing

Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 350
Not applicableStudy completedNCT00073424
What this trial is testing

Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Large-scale testing (Phase 3)Study completedNCT00004583
What this trial is testing

A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy

Who this might be right for
HIV Infections
Abbott 660
Testing effectiveness (Phase 2)Study completedNCT00002442
What this trial is testing

Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome
Not applicableStudy completedNCT00002369
What this trial is testing

A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Bristol-Myers Squibb 200
Early research (Phase 1)Study completedNCT00002380
What this trial is testing

The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Who this might be right for
HIV Infections
Hoffmann-La Roche 28
Large-scale testing (Phase 3)UnknownNCT00009061
What this trial is testing

Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 624
Not applicableStudy completedNCT00000932
What this trial is testing

The Long-Term Outcomes of HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3,669
Testing effectiveness (Phase 2)Ended earlyNCT00002418
What this trial is testing

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Who this might be right for
HIV Infections
Bristol-Myers Squibb 25
Large-scale testing (Phase 3)UnknownNCT00008554
What this trial is testing

Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy

Who this might be right for
HIV Infections
Glaxo Wellcome 210
Not applicableStudy completedNCT00002400
What this trial is testing

Two Anti-HIV Drug Combinations in HIV-Infected Patients

Who this might be right for
HIV Infections
Pharmacia and Upjohn 45
Testing effectiveness (Phase 2)WithdrawnNCT00006339
What this trial is testing

Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT00002202
What this trial is testing

A Comparison of 141W94 and Indinavir in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome 460
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation